JAPANESE PHARMA DAIICHI SANKYO TO LAUNCH LARGE-SCALE CLINICAL TRIAL OF ITS mRNA COVID-19 VACCINE

Highlights

• According to Yabuto, the company plans to apply for government authorization based on the outcome of the trial

Daiichi Sankyo, a pharmaceutical company from Japan is prepping up to commence a large-scale clinical trial of its experimental coronavirus mRNA vaccine most probably this year end. 

Talking in an interview with broadcaster NHK, Yabuto Masayuki who happens to be in charge of vaccine....